-
Centre to buy Covishield and Covaxin at revised rates
expresspharma
July 20, 2021
The price of each dose of Covishield amounts to Rs 215.25, and Covaxin Rs 225.75, including taxes.
-
DSRU says more research needed to understand immunocompromised patients' responses to COVID-19 vaccines
pharmatimes
July 19, 2021
The UK’s independent Drug Safety Research Unit (DSRU) has called for more research to understand the weaker COVID-19 vaccine protection for immunocompromised patients.
-
Pfizer-BioNTech’s Covid-19 vaccine receives FDA priority review
pharmaceutical-technology
July 19, 2021
The US Food and Drug Administration (FDA) has granted priority review designation to biologics license application (BLA) submitted by Pfizer and BioNTech for their Covid-19 vaccine.
-
Heat-tolerant COVID-19 vaccine from IISc effective against all major SARS-CoV-2 variants: Study
expresspharma
July 19, 2021
The research, published in the ACS Infectious Diseases journal on Thursday, showed that vaccine formulations by IISc-incubated biotech start-up Mynvax triggered a strong immune response in mice.
-
FDA to Prioritize Full Approval for Pfizer COVID-19 Vaccine
drugs
July 19, 2021
Pfizer Inc. announced on Friday that the U.S. Food and Drug Administration has granted priority review to its COVID-19 vaccine, positioning the vaccine for full approval by January.
-
COVID-19 vaccine market set to reach $19.5 bn by 2026: GlobalData
expresspharma
July 15, 2021
COVID-19 vaccines based on mRNA technology dominate the 7MM in 2021 with a market share of 95.4 per cent and $9.5 billion in sales for Pfizer/BioNTech and $3.5 billion for Moderna.
-
COVID-19 vaccine doses administered in India so far surpasses 39 crores: Health Ministry
expresspharma
July 15, 2021
Cumulatively, 11,78,70,724 people in the age group 18-44 years have received the first dose and 41,92,141 their second dose since the start of phase three of the vaccination drive.
-
Pharmacovigilance Risk Assessment Committee (PRAC) meeting highlights, July 2021
europeanpharmaceuticalreview
July 14, 2021
The Pharmacovigilance Risk Assessment Committee (PRAC) provided safety warnings on COVID-19 vaccines, and found no evidence linking Zynteglo to blood cancer.
-
FlowMetric Life Sciences Inc. Introduces the Breakthrough VaxEffect™ COVID-19 Vaccine Immune Response Test
americanpharmaceuticalreview
July 14, 2021
FlowMetric Life Sciences Inc. announced the launch of VaxEffect™ COVID-19 Vaccine Immune Response Test, a unique and powerful platform exclusively created to quantitatively assess and track, now and over time, an individual's immune response to any of ...
-
US FDA adds new warning on J&J COVID-19 vaccine for Guillain-Barre´ syndrome
expresspharma
July 14, 2021
It said J&J vaccine recipients should seek medical attention if they have symptoms including weakness or tingling sensations, difficulty walking or difficulty with facial movements.